OBJECTIVE: To assess maternal mortality after delayed treatment for invasive @entity2622 during pregnancy and to improve fetal outcome. STUDY DESIGN: @entity3 was diagnosed in 12 pregnant @entity1 between 1 January 1977 and 1 January 1996. The medical records were examined retrospectively, and a literature survey was performed. RESULTS: The incidence of @entity2622 in our population was 1.1 per 10000 pregnancies. Ten @entity1 had FIGO (International Federation of Gynaecology and Obstetrics) stage IB lesions, two @entity1 stage IIA/B. Eight @entity1 had @entity957 , four @entity420 . In six @entity1 with a gestation of >20 weeks and stage IB/IIA we postponed treatment for 2 to 10 weeks to optimize fetal outcome. In six @entity1 with a gestation of <20 weeks and stage IB/IIB we recommended immediate radical hysterectomy. Fetal outcome in the delayed-treatment group was excellent. Two @entity1 , one in each group, died after a relapse. The remaining five @entity1 of the delayed-treatment group are disease-free after a median follow-up of 82 months. CONCLUSION: Delayed treatment to achieve greater fetal maturity is a reasonable option for @entity1 with @entity189 of <stage IIB, @entity5 and a gestation of >20 weeks.

XXXX during pregnancy: outcome of planned delay in treatment.

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['non-bulky tumours'] @entity957 :: ('MESH:D002294', 'Disease') :: ['squamous cell carcinoma'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['carcinoma of the uterine cervix', 'cervical carcinoma'] @entity189 :: ('MESH:D002277', 'Disease') :: ['cervix carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['Invasive cervical cancer'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinoma']
@entity2622 :: (MESH:D002583,Disease) :: ['Cervical carcinoma']
